<code id='2CB3A3D4FE'></code><style id='2CB3A3D4FE'></style>
    • <acronym id='2CB3A3D4FE'></acronym>
      <center id='2CB3A3D4FE'><center id='2CB3A3D4FE'><tfoot id='2CB3A3D4FE'></tfoot></center><abbr id='2CB3A3D4FE'><dir id='2CB3A3D4FE'><tfoot id='2CB3A3D4FE'></tfoot><noframes id='2CB3A3D4FE'>

    • <optgroup id='2CB3A3D4FE'><strike id='2CB3A3D4FE'><sup id='2CB3A3D4FE'></sup></strike><code id='2CB3A3D4FE'></code></optgroup>
        1. <b id='2CB3A3D4FE'><label id='2CB3A3D4FE'><select id='2CB3A3D4FE'><dt id='2CB3A3D4FE'><span id='2CB3A3D4FE'></span></dt></select></label></b><u id='2CB3A3D4FE'></u>
          <i id='2CB3A3D4FE'><strike id='2CB3A3D4FE'><tt id='2CB3A3D4FE'><pre id='2CB3A3D4FE'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:4447

          Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

          advertisement

          For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Anavex keeps shifting the goalposts in its clinical trials
          Anavex keeps shifting the goalposts in its clinical trials

          MollyFerguson/STATAnavexLifeSciencesisinatoughspot.Theserialdissemblerofclinicaltrialresultsmightbef

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Lawmakers grill UnitedHealth CEO on Change cyberattack

          KentNishimura/GettyImagesOnWednesday,UnitedHealthCEOAndrewWittyappearedbeforeCongresstoanswerforwhat